Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial

Related

• 

  AMD Neovascular Expert Panel

  Robert L. Avery, MD

  Nizar S Abdelfattah, M.D.

  Nancy M. Holekamp, MD, FASRS

  Peter K. Kaiser, MD FASRS

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2016

• 

  Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2019

• 

  Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

  Thomas A. Ciulla, MD, MBA, FASRS

  Updates from the Field

  2017